Write For Us

Biotech ‘offers upside’ within U.S. healthcare sector

Sponsored Post Vitamin D2 Canada Persia
35 Views
Published
U.S. healthcare stocks may be about to benefit from the normalization of demand for health services as the pandemic winds down. John Stoltzfus of Oppenheimer Asset Management explains why biotechnology ‘offers upside’ within the sector.

#SectorsUpclose #USStockMarket #HealthcareStocks #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, business, finance
Sign in or sign up to post comments.
Be the first to comment